Vilobelimab

Generic name: vilobelimab [ VIL-oh-BEL-i-mab ]
Brand name: Gohibic
Dosage form: intravenous solution (10 mg/mL)
Drug class: Miscellaneous antivirals

Medically reviewed by Drugs.com on Apr 12, 2023. Written by Cerner Multum.

What is vilobelimab?

COVID-19 is a serious disease caused by a coronavirus called SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). COVID-19 is spread from person to person through the air.

COVID-19 can affect your lungs or other organs. Symptoms may be mild or serious and include fever, chills, cough, sore throat, shortness of breath, tiredness, body aches, headache, loss of taste or smell, runny or stuffy nose, nausea, vomiting, or diarrhea.

The US Food and Drug Administration (FDA) has authorized emergency use of vilobelimab to treat COVID-19 in hospitalized adults when started within 48 hours of invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO, a heart-lung machine that helps increase oxygen in the blood). vilobelimab has not been approved by the FDA to treat COVID-19.

Vilobelimab may also be used for purposes not listed in this medication guide.

Vilobelimab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Vilobelimab may cause serious side effects. Call your doctor at once if you have:

• signs of infection--fever, chills, sore throat, body aches, unusual tiredness, loss of appetite, bruising or bleeding.

Common side effects of vilobelimab may include:

• confusion;

• constipation;

• rash;

• irregular heartbeats;

• pain, swelling, or warmth in one leg;

• pain and burning when you urinate;

• chest pain, breathing problems, shortness of breath;

• severe headache, blurred vision, pounding in your neck or ears;

• easy bruising, unusual bleeding, purple or red spots under your skin;

• cold symptoms such as stuffy nose, sneezing, sore throat;

• symptoms of sepsis--confusion, fever or chills, severe drowsiness, fast heartbeats, rapid breathing, feeling very ill; or

• symptoms of herpes virus--cold sores around your mouth, skin sores or blisters, itching, tingling, burning pain in your thigh or lower back.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Related/similar drugs

Paxlovid, Lagevrio, Actemra, molnupiravir, remdesivir, tocilizumab

Warnings

The US Food and Drug Administration (FDA) has authorized emergency use of vilobelimab to treat COVID-19 in hospitalized adults when started within 48 hours of invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO, a heart-lung machine that helps increase oxygen in the blood). vilobelimab has not been approved by the FDA to treat COVID-19.

Before taking this medicine

Tell your doctor if you have:

• allergies;

• an infection other than COVID-19; or

• any serious illnesses.

Tell your doctor if you are pregnant or plan to become pregnant, or breastfeeding or plan to breastfeed.

How is vilobelimab given?

Follow all directions on your prescription label and read all medication guides or instruction sheets.

Vilobelimab is injected into a vein by a healthcare provider in a hospital.

Vilobelimab dosing information

Usual Adult Dose for COVID-19:

For investigational use only

800 mg IV for up to 6 doses as follows:
-Treatment should be started within 48 hours of intubation (Day 1) followed by administration on Days 2, 4, 8, 15, and 22 as long as the patient is hospitalized (even if discharged from intensive care unit).

Comments:
-The US FDA issued an Emergency Use Authorization (EUA) to allow the emergency use of vilobelimab for the treatment of coronavirus disease 2019 (COVID-19) in hospitalized patients when initiated within 48 hours of receiving invasive mechanical ventilation (IMV) or extracorporeal membrane oxygenation (ECMO); this drug is not approved by the US FDA for this use.
-For additional information: https://www.fda.gov/drugs/emergency-preparedness-drugs/emergency-use-authorizations-drugs-and-non-vaccine-biological-products

Use: For the treatment of COVID-19 in hospitalized patients when initiated within 48 hours of receiving IMV or ECMO

What happens if I miss a dose?

In a medical setting you are not likely to miss a dose.

What happens if I overdose?

In a medical setting an overdose would be treated quickly.

What should I avoid while receiving vilobelimab?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

What other drugs will affect vilobelimab?

Other drugs may affect vilobelimab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Copyright 1996-2024 Cerner Multum, Inc. Version: 1.01.